NCT05680935View on ClinicalTrials.gov

microRNAs in the Diagnosis of Atherosclerotic Plaque Instability

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

September 5, 2022

Primary Completion Date

February 28, 2024

Study Completion Date

February 29, 2024

Conditions
Atherosclerosis of Artery
Interventions
DIAGNOSTIC_TEST

blood microRNA

all patients will receive blood (20 ml) from the cubital vein for microRNA isolation.

DIAGNOSTIC_TEST

plaque and intima microRNA

The resulting surgical material will be sent for microRNA isolation.

DIAGNOSTIC_TEST

histological examination of the plaque

The resulting surgical material (atherosclerotic plaque) will be sent for histological examination.

DIAGNOSTIC_TEST

blood level trimethyl N-oxide

all patients will receive blood (20 ml) from the cubital vein for determination of plasma trimethyl N-oxide (TMAO) content.

Trial Locations (1)

119991

I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow

All Listed Sponsors
lead

I.M. Sechenov First Moscow State Medical University

OTHER